Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

During the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 conference, Drs. Laura Coates and Atul Deodhar debated whether axial psoriatic arthritis (axPsA) is the same as ankylosing spondylitis (AS) with psoriasis. Dr. Coates argued that AS represents a spectrum...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Coates, LC, Deodhar, A
Format:	Journal article
Język:	English
Wydane:	Journal of Rheumatology Publishing 2023

Podobne zapisy

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
od: Alba Erra, i wsp.
Wydane: (2022-11-01)

Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
od: Elena Conesa-Nicolás, i wsp.
Wydane: (2021-01-01)

Modern imaging techniques in the diagnosis of axial spondylitis: similarities and differences between axial psoriatic arthritis and ankylosing spondylitis
od: A. V. Sukhinina, i wsp.
Wydane: (2024-02-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
od: Lubrano E, i wsp.
Wydane: (2016-10-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
od: E. E. Gubar, i wsp.
Wydane: (2023-08-01)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
od: Coates, L, i wsp.
Wydane: (2016)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
od: A. P. Rebrov, i wsp.
Wydane: (2015-03-01)

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
od: Andrea Rubbert-Roth, i wsp.
Wydane: (2023-11-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
od: M. Rossini, i wsp.
Wydane: (2015-03-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
od: T. V. Dubinina, i wsp.
Wydane: (2023-02-01)

Identification of psoriatic arthritis in patients with psoriasis
od: Coates, LC, i wsp.
Wydane: (2023)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
od: Vivekanantham, A, i wsp.
Wydane: (2024)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
od: Chia-Jung Tsai, i wsp.
Wydane: (2023-09-01)

The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
od: Ahmet Karataş, i wsp.
Wydane: (2020-10-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
od: Viola Sacchi, i wsp.
Wydane: (2010-06-01)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
od: Ashley Elliott, i wsp.
Wydane: (2019-06-01)

How should we define disease and outcomes in axial psoriatic arthritis?
od: Coates, LC
Wydane: (2021)

Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
od: Bolge SC, i wsp.
Wydane: (2017-03-01)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
od: Iain B McInnes, i wsp.
Wydane: (2020-02-01)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
od: Lars Erik Kristensen, i wsp.
Wydane: (2024-05-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
od: M. Elaine Husni, i wsp.
Wydane: (2022-03-01)

Ankylosing spondylitis-axial spondyloarthritis
od: Aanand Narayan Malaviya
Wydane: (2017-01-01)

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
od: A. Deodhar, i wsp.
Wydane: (2019-05-01)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
od: Braun, J, i wsp.
Wydane: (2023)

Methotrexate in psoriasis and psoriatic arthritis
od: Coates, L, i wsp.
Wydane: (2020)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
od: Colombo GL, i wsp.
Wydane: (2018-08-01)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
od: Alexis Ogdie, i wsp.
Wydane: (2024-09-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
od: Sumera Ghani, i wsp.
Wydane: (2023-06-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
od: Nikolay N. Murashkin, i wsp.
Wydane: (2020-12-01)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
od: Peter Nash, i wsp.
Wydane: (2023-10-01)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
od: Gia Deyab, i wsp.
Wydane: (2017-01-01)

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
od: Peter Nash, i wsp.
Wydane: (2023-02-01)

Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset
od: Sarah B. Lieber, i wsp.
Wydane: (2022-04-01)

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study
od: Joachim Sieper, i wsp.
Wydane: (2019-06-01)

Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
od: Fatma Mohammed Aboud, i wsp.
Wydane: (2023-03-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
od: Gerd R. Burmester, i wsp.
Wydane: (2024-04-01)

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis
od: C. Brock, i wsp.
Wydane: (2021-01-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
od: Krzysztof Bonek, i wsp.
Wydane: (2022-04-01)

Complications of primary total hip arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and primary osteoarthritis
od: Qiang Lian, i wsp.
Wydane: (2022-10-01)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
od: Ehab F. Girbash, i wsp.
Wydane: (2023-01-01)